Pulmonary tuberculosis: Association between extent of the residual pulmonary lesion and alteration in the lung function;Tuberculose pulmonar: Associação entre extensão de lesão pulmonar residual e alteração da função pulmonar

Revista da Associacao Medica Brasileira

Volumn 54, Issue 5, 2008, Pages 406-410

  Cruz, Rita De Cássia Santa ^a,b   De Albuquerque, Maria De Fátima Pessoa Militão ^a   Campelo, Antônio Roberto Leite ^a   E Silva, Eduardo Just Da Costa ^a   Mazza, Edmílson ^a   Menezes, Renata Carneiro ^a   Kosminsky, Samuel ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b NONE   (Brazil)

Author keywords

Pulmonary tuberculosis; Respiratory dysfunction; Spirometry

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHI SQUARE DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; DRINKING BEHAVIOR; FEMALE; HOSPITALIZATION; HUMAN; LUNG; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; REFERENCE VALUE; SMOKING; SPIROMETRY; VITAL CAPACITY;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; BRAZIL; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; TUBERCULOSIS, PULMONARY; VITAL CAPACITY; YOUNG ADULT;

EID: 56349119973     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302008000500012     Document Type: Article

References (25)

1. Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen N. Pulmonary tuberculosis treated with directly observed therapy- serial changes in lung structure and function. Chest. 1998;113:933-42.
2. Kim HY, Song GS, Goo JM, Lee JS, Lee KS, Lim TH: Thoracic sequelae and complications of tuberculosis. Radiographics. 2001;21:839-60.
3. Job JRPP, Gozzano JOA, Bernardes Jr OR, Garcia RH, Miralhes OJC, Miranda MAP. Informações que antecederam o diagnóstico de Tuberculose pulmonar e tempo decorrido até o início do tratamento em pacientes matriculados em centro de saúde, São Paulo (Brasil). Rev Saúde Púbica. 1986;20:21-5.
4. Santos MAPS, Albuquerque MFPM, Ximenes RAA, Lucena-Silva NLCL, Braga C, Campelo ARL, et al. Risk factors for treatment delay in pulmonary tuberculosis in Recife, Brazil. BMC Public Health. 2005;5:1-8.
5. Humphries MJ, Byfield SP, Darbyshire JH, Davies PD, Nunn AJ, et al. Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Br J Dis Chest. 1984;78:149-58.
6. Miranda G, Diaz JC Arancibia P, Antolini M, Diaz C, Vidal A: Manifestaciones radiográficas de la tuberculosis pulmonar. Rev Chil Radiol. 2004;10:178-82.
7. Jones BE, Ryu R, Yang Z, Cave MD, Pogoda JM, Otaya M, et al. Chest radiographic findings in patients with recent or remote infection. Am J Resp Crit Care Med.1997;156:1270-3.
8. Ribeiro SN, Gehardt FG, Silva JRL, Fonseca L, Gontijo P, Sant' Anna CC, et al. Tuberculose. In: Pneumologia. 4a ed. São Paulo: Atheneu; 1995. p.379-448.
9. Sociedade Brasileira de Pneumologia e Tisiologia (SBPT). Diretrizes para testes de função pulmonar. J Pneumol. 2002;28.
10. Silva LCC, Rubin AS, Silva LMC. Avaliação funcional pulmonar. In: Silva LCC, organizador. Condutas em pneumologia. São Paulo: Revinter; 2001. v.1, p.109-21.
11. Winer-Muram HT, Rubin, AS. Thoracic complications of tuberculosis. J Thorac Imaging. 1990;5:46-63.
12. Sociedade Brasileira de Pneumologia e Tisiologia (SBPT). Consenso Brasileiro sobre terminologia dos descritores de tomografia computadorizada do tórax. J Pneumol. 2005;31:149-55.
13. Pereira LFF. Manual sobre tabagismo. Sociedade Brasileira de Pneumologia e Tisiologia. [citado 21 maio 2006]. Disponível em: http://www.sbpt.org. br.
14. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, Bouvet E. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis. Chest. 1999;115:1248-53.
15. Biz E, Pereira CAP, Moura LAR, Sesso R, Vaz MLS, Silva Filho AP, et al. The use of cyclosporine modifies the clinical and histopathological presentation of tuberculosis after renal transplantation. Rev Inst Med Trop São Paulo. 2000;42:225-30.
16. Viva Mais. Programa de prevenção ao uso de substâncias psicoativas lícitas e ilícitas. São Paulo: UNICAMP; 2006. [citado 14 maio 2006]. Disponível em: http://www.prdu.unicamp.br/ vivamais/.
17. Altman DG. Practical statistics for medical research. London: Chapman & Hall CRC; 1991. p.611.
18. th ed. New Jersey: Prentice Hall; 1999. p.929.
19. Plit ML, Anderson R, Van Rensburg CE, Page-Shipp L, Blott JA, Fresen JL, et al. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J. 1998;12:351-6.
20. Altet-Gómez MN, Megías JÁ, Soler JC, Auge CM, Fuentes MAJ, Galvão MLS, et al. Estúdio del retraso diagnóstico de la tuberculosis pulmonar sintomática. Arch Bronconeumol. 2003;39:146-52.
21. Campos EP, Campos CEOP, Cataneo AJM. Função pulmonar comparativa da paracoccidioidomicose com a tuberculose. J Pneumol. 1990;16:62-3.
22. Ramos LMM, Sulmonett N, Ferreira CS, Henriques JF, Miranda SS: Perfil funcional de pacientes portadores de seqüela de tuberculose de um hospital universitário. J Pneumol. 2006;32:43-7.
23. Lee JH, Chung HS. Bronchoscopic, radiologic and pulmonary function evaluation of endobronchial tuberculosis. Respirology. 2000;5:411-7.
24. a ed. Rio de Janeiro: Manole; 1992. v.3, p.1895-14.
25. Im JG, Itoh H, Shim YS, Ahn J, Han MC, Noma S. Pulmonary tuberculosis: CT findings: early active disease and sequential change with antituberculous therapy. Radiology. 1993;186:653-60.